M&A
Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals
Melinta Therapeutics
PR-M06-20-NI-027-1493Jun 19, 2020
Bankruptcy
Melinta Therapeutics Announces Restructuring and Files Bankruptcy
Melinta Therapeutics
PR-M01-20-NI-008Jan 03, 2020
Leadership
Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan
Melinta Therapeutics
PR-M08-19-NI-034Aug 13, 2019